Semaglutide
Quiz Summary
0 of 8 Questions completed
Questions:
Information
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
Results
Results
0 of 8 Questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Categories
- Not categorized 0%
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- Current
- Review
- Answered
- Correct
- Incorrect
-
Question 1 of 8
1. Question
What is Wegovy® indicated for in adults?
CorrectIncorrect -
Question 2 of 8
2. Question
What is the Body Mass Index (BMI) requirement for adults to be eligible for Wegovy® treatment?
CorrectIncorrect -
Question 3 of 8
3. Question
What is the recommended starting dose of Wegovy® per week for patients?
CorrectIncorrect -
Question 4 of 8
4. Question
What is the main contributor to obesity-associated cellular inflammation, according to the provided information?
CorrectIncorrect -
Question 5 of 8
5. Question
What percentage of weight loss was sustained over 68 weeks in people with obesity treated with semaglutide 2.4mg, as per the STEP 1 trial?
CorrectIncorrect -
Question 6 of 8
6. Question
Which adverse event was NOT listed as a very common side effect of Wegovy® in the STEP trials?
CorrectIncorrect -
Question 7 of 8
7. Question
What is the likely outcome when a patient stops taking Wegovy®?
CorrectIncorrect -
Question 8 of 8
8. Question
What is the primary safety concern associated with Wegovy® use?
CorrectIncorrect